The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


LAMICTAL

5 Milligram Dispersable Tablet

PCO ManufacturingPPA0465/092/005

Main Information

Trade NameLAMICTAL
Active SubstancesLAMOTRIGINE
Strength5 Milligram
Dosage FormDispersable Tablet
Licence HolderPCO Manufacturing
Licence NumberPPA0465/092/005

Group Information

ATC CodeN03AX09 lamotrigine

Status

Authorised/WithdrawnAuthorised
Licence Issued11/07/2003
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back